img

Post-pandemic Era-Global Human Vaccines Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type INDUSTRY PRODUCTION


Published on: 2021-01-05 | No of Pages : 96 | Industry : Pharma & Healthcare Research Center

Publisher : X | Format : PDF

Post-pandemic Era-Global Human Vaccines Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Summary

This study analysis was given on a worldwide scale, for instance, present and historical Human Vaccines growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of Human Vaccines production, Human Vaccines revenue, Human Vaccines consumption and Human Vaccines price.

According to the current situation, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. XYZResearch published a report for global Human Vaccines market in this environment.

In terms of revenue, this research report indicated that the global Human Vaccines market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Human Vaccines industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the production and revenue data in each of the sub-segments.
The AstraZeneca plc aims at producing XX Human Vaccines in 2020, with XX % production to take place in global market, Bavarian Nordic accounts for a volume share of XX %.

At the upcoming analysis, this report discusses industrial policy, economic environment, in addition to the COVID-19 impact and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Human Vaccines Market by XYZResearch Include
NorthAmerica
Asia
Europe
Middle East & Africa
South America
Competitive Analysis; Who are the Major Players in Human Vaccines Market?
AstraZeneca plc
Bavarian Nordic
Bharat Biotech
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co, Inc.
Mymetics
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Shenzhen Kangtai Biological Products Co., Ltd.
Takeda Pharmaceutical Company Limited
Major Type of Human Vaccines Covered in XYZResearch report:
Conjugate
Recombinant
Inactivated
Combination
Attenuated
Others
Application Segments Covered in XYZResearch Market
Pediatrics
Adolescents
Adults
Geriatrics

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Human Vaccines Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Conjugate -Product Introduction and Major Manufacturers
1.1.2 Recombinant -Product Introduction and Major Manufacturers
1.1.3 Inactivated -Product Introduction and Major Manufacturers
1.1.4 Combination -Product Introduction and Major Manufacturers
1.1.5 Attenuated -Product Introduction and Major Manufacturers
1.1.6 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2019-2026)
2.2 Regional Market Share in Terms of Revenue (2019-2026)
2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Human Vaccines Market Assessment by Type
3.1 Global Human Vaccines Production by Type (2015-2026)
3.2 Global Human Vaccines Revenue by Type (2015-2026)
3.3 North America Human Vaccines Production and Revenue by Type (2015-2026)
3.4 Asia Human Vaccines Production and Revenue by Type (2015-2026)
3.5 Europe Human Vaccines Production and Revenue by Type (2015-2026)
3.6 Middle East & Africa Human Vaccines Production and Revenue by Type (2015-2026)
3.7 South America Human Vaccines Production and Revenue by Type (2015-2026)

4 Global Human Vaccines Market Assessment by Application
4.1 Historical & Forecast Global Human Vaccines Consumption, Different Application Field (2015-2026)
4.2 Historical & Forecast North America Human Vaccines Consumption, Different Application Field (2015-2026)
4.3 Historical & Forecast Asia Human Vaccines Consumption, Different Application Field (2015-2026)
4.4 Historical & Forecast Europe Human Vaccines Consumption, Different Application Field (2015-2026)
4.5 Historical & Forecast Middle East & Africa Human Vaccines Consumption, Different Application Field (2015-2026)
4.6 Historical & Forecast South America Human Vaccines Consumption, Different Application Field (2015-2026)

5 North America
5.1 US Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.2 Canada Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.3 Mexico Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
6.1 China Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.2 Japan Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.3 India Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.4 Korea Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.5 Southeat Asia Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
7.1 Germany Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.2 UK Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.3 France Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.4 Russia Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.5 Italy Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
8.1 Saudi Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.2 UAE Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.3 Egypt Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.4 Nigeria Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.5 South Africa Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
9.1 Brazil Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.2 Argentina Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.3 Colombia Human Vaccines Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Human Vaccines Average Price Trend
10.1 Market Price for Each Type of Human Vaccines in North America (2015-2026)
10.2 Market Price for Each Type of Human Vaccines in Asia (2015-2026)
10.3 Market Price for Each Type of Human Vaccines in Europe (2015-2026)
10.4 Market Price for Each Type of Human Vaccines in Middle East & Africa (2015-2026)
10.5 Market Price for Each Type of Human Vaccines in South America (2015-2026)

11 Value Chain (Impact of COVID-19)
11.1 Human Vaccines Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Human Vaccines Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors

12 Human Vaccines Competitive Analysis
12.1 AstraZeneca plc
12.1.1 AstraZeneca plc Company Profiles
12.1.2 AstraZeneca plc Product Introduction
12.1.3 AstraZeneca plc Human Vaccines Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Bavarian Nordic
12.2.1 Bavarian Nordic Company Profiles
12.2.2 Bavarian Nordic Product Introduction
12.2.3 Bavarian Nordic Human Vaccines Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 Bharat Biotech
12.3.1 Bharat Biotech Company Profiles
12.3.2 Bharat Biotech Product Introduction
12.3.3 Bharat Biotech Human Vaccines Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 CSL Limited
12.4.1 CSL Limited Company Profiles
12.4.2 CSL Limited Product Introduction
12.4.3 CSL Limited Human Vaccines Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 Mymetics
12.5.1 Emergent BioSolutions, Inc. Company Profiles
12.5.2 Emergent BioSolutions, Inc. Product Introduction
12.5.3 Emergent BioSolutions, Inc. Human Vaccines Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 GlaxoSmithKline plc
12.6.1 GlaxoSmithKline plc Company Profiles
12.6.2 GlaxoSmithKline plc Product Introduction
12.6.3 GlaxoSmithKline plc Human Vaccines Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Profiles
12.7.2 Johnson & Johnson Product Introduction
12.7.3 Johnson & Johnson Human Vaccines Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 Merck & Co, Inc.
12.8.1 Merck & Co, Inc. Company Profiles
12.8.2 Merck & Co, Inc. Product Introduction
12.8.3 Merck & Co, Inc. Human Vaccines Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 Mymetics
12.9.1 Mymetics Company Profiles
12.9.2 Mymetics Product Introduction
12.9.3 Mymetics Human Vaccines Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
12.10 Novartis AG
12.10.1 Novartis AG Company Profiles
12.10.2 Novartis AG Product Introduction
12.10.3 Novartis AG Human Vaccines Production, Revenue (2015-2020)
12.10.4 SWOT Analysis
12.11 Pfizer, Inc.
12.12 Sanofi S.A.
12.13 Shenzhen Kangtai Biological Products Co., Ltd.
12.14 Takeda Pharmaceutical Company Limited
13 Conclusion


List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Human Vaccines Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table Regional Market Share in Terms of Production (2019-2026)
Figure Regional Market Share in Terms of Production (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Human Vaccines Production (K Unit) by Type (2015-2026)
Figure Global Human Vaccines Production (K Unit) and Growth Rate (2015-2026)
Figure Global Human Vaccines Production Market Share (%) by Type (2019 -2020)
Table Global Human Vaccines Revenue (Million USD) by Type (2015-2026)
Figure Global Human Vaccines Revenue (Million USD) and Growth Rate (2015-2026)
Figure Global Human Vaccines Revenue Market Share (%) by Type (2019-2020)
Figure North America Human Vaccines Production (K Unit) by Type (2015-2026)
Figure North America Human Vaccines Production (K Unit) and Growth Rate (2015-2026)
Figure North America Human Vaccines Revenue (Million USD) by Type (2015-2026)
Figure North America Human Vaccines Revenue (Million USD) and Growth Rate (2015-2026)
Figure Asia Human Vaccines Production (K Unit) by Type (2015-2026)
Figure Asia Human Vaccines Production (K Unit) and Growth Rate (2015-2026)
Figure Asia Human Vaccines Revenue (Million USD) by Type (2015-2026)
Figure Asia Human Vaccines Revenue (Million USD) and Growth Rate (2015-2026)
Figure Europe Human Vaccines Production (K Unit) by Type (2015-2026)
Figure Europe Human Vaccines Production (K Unit) and Growth Rate (2015-2026)
Figure Europe Human Vaccines Revenue (Million USD) by Type (2015-2026)
Figure Europe Human Vaccines Revenue (Million USD) and Growth Rate (2015-2026)
Figure Middle East & Africa Human Vaccines Production (K Unit) by Type (2015-2026)
Figure Middle East & Africa Human Vaccines Production (K Unit) and Growth Rate (2015-2026)
Figure Middle East & Africa Human Vaccines Revenue (Million USD) by Type (2015-2026)
Figure Middle East & Africa Human Vaccines Revenue (Million USD) and Growth Rate (2015-2026)
Figure South America Human Vaccines Production (K Unit) by Type (2015-2026)
Figure South America Human Vaccines Production (K Unit) and Growth Rate (2015-2026)
Figure South America Human Vaccines Revenue (Million USD) by Type (2015-2026)
Figure South America Human Vaccines Revenue (Million USD) and Growth Rate (2015-2026)
Table Historical & Forecast Human Vaccines Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2015-2026)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Human Vaccines Different Application Field Consumption (K Unit)
Figure North America Human Vaccines Consumption (K Unit) and Growth Rate (2015-2026)
Figure North America Human Vaccines Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Human Vaccines Different Application Field Consumption (K Unit)
Figure Asia Human Vaccines Consumption (K Unit) and Growth Rate (2015-2026)
Figure Asia Human Vaccines Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Human Vaccines Different Application Field Consumption (K Unit)
Figure Europe Human Vaccines Consumption (K Unit) and Growth Rate (2015-2026)
Figure Europe Human Vaccines Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Human Vaccines Different Application Field Consumption (K Unit)
Figure Middle East & Africa Human Vaccines Consumption (K Unit) and Growth Rate (2015-2026)
Figure Middle East & Africa Human Vaccines Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Human Vaccines Different Application Field Consumption (K Unit)
Figure South America Human Vaccines Consumption (K Unit) and Growth Rate (2015-2026)
Figure South America Human Vaccines Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Human Vaccines Different Application Field Consumption (K Unit)
Table US Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Human Vaccines Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Human Vaccines in China
Table Market Price (USD/Unit) for Each Type of Human Vaccines in EU
Table Market Price (USD/Unit) for Each Type of Human Vaccines in USA
Table Market Price (USD/Unit) for Each Type of Human Vaccines in Japan
Table Market Price (USD/Unit) for Each Type of Human Vaccines in India
Table Market Price (USD/Unit) for Each Type of Human Vaccines in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Human Vaccines in South America
Figure Value Chain Structure of Human Vaccines
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Human Vaccines
Figure Cost Structure of Human Vaccines in 2020
Table Distributors/Traders List
Table AstraZeneca plc Profiles
Table AstraZeneca plc Human Vaccines Product Introduction
Figure AstraZeneca plc Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure AstraZeneca plc SWOT Analysis
Table Bavarian Nordic Profiles
Table Bavarian Nordic Human Vaccines Product Introduction
Figure Bavarian Nordic Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Bavarian Nordic SWOT Analysis
Table Bharat Biotech Profiles
Table Bharat Biotech Human Vaccines Product Introduction
Figure Bharat Biotech Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Bharat Biotech SWOT Analysis
Table CSL Limited Profiles
Table CSL Limited Human Vaccines Product Introduction
Figure CSL Limited Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure CSL Limited SWOT Analysis
Table Emergent BioSolutions, Inc. Profiles
Table Emergent BioSolutions, Inc. Human Vaccines Product Introduction
Figure Emergent BioSolutions, Inc. Pharma & Healthcare Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Emergent BioSolutions, Inc. SWOT Analysis
Table GlaxoSmithKline plc Profiles
Table GlaxoSmithKline plc Human Vaccines Product Introduction
Figure GlaxoSmithKline plc Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure GlaxoSmithKline plc SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Human Vaccines Product Introduction
Figure Johnson & Johnson Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Johnson & Johnson SWOT Analysis
Table Merck & Co, Inc. Profiles
Table Merck & Co, Inc. Human Vaccines Product Introduction
Figure Merck & Co, Inc. Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Merck & Co, Inc. SWOT Analysis
Table Mymetics Profiles
Table Mymetics Human Vaccines Product Introduction
Figure Mymetics Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Mymetics SWOT Analysis
Table Novartis AG Profiles
Table Novartis AG Human Vaccines Product Introduction
Figure Novartis AG Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Novartis AG SWOT Analysis
Table Pfizer, Inc. Profiles
Table Pfizer, Inc. Human Vaccines Product Introduction
Figure Pfizer, Inc. Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Pfizer, Inc. SWOT Analysis
Table Sanofi S.A. Profiles
Table Sanofi S.A. Human Vaccines Product Introduction
Figure Sanofi S.A. Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Sanofi S.A. SWOT Analysis
Table Shenzhen Kangtai Biological Products Co., Ltd. Profiles
Table Shenzhen Kangtai Biological Products Co., Ltd. Human Vaccines Product Introduction
Figure Shenzhen Kangtai Biological Products Co., Ltd. Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Shenzhen Kangtai Biological Products Co., Ltd. SWOT Analysis
Table Takeda Pharmaceutical Company Limited Profiles
Table Takeda Pharmaceutical Company Limited Human Vaccines Product Introduction
Figure Takeda Pharmaceutical Company Limited Human Vaccines Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)